Tom Kronbach
Management
BioCrea
Germany
Biography
Tom Kronbach founded BioCrea in 2010 as a management-buy-out from Biotie Therapies. He established an international management team to produce first-in-class drugs from leading scientific concepts with robust and proven lead optimization skills. Previously, Tom was a founder and CSO of elbion Group, which was acquired by Biotie Therapies in 2008, where he continued as CSO and Managing Director. Tom played the key role in the conception and negotiation of deals and collaborations with Boehringer Ingelheim, Pfizer, Wyeth and GlaxoSmithKline.
Research Interest
Pharmaceutical Science
